Search

Author/Creator Redlich, Garry L.

1. Phase 1b dose-escalation, safety, and pharmacokinetic study of IC14, a monoclonal antibody against CD14, for the treatment of amyotrophic lateral sclerosis. Issue 42 (22nd October 2021)

Authors:
Henderson, Robert D.; Agosti, Jan M.; McCombe, Pamela A.; Thorpe, Kathryn; Heggie, Susan; Heshmat, Saman; Appleby, Mark W.; Ziegelaar, Brian W.; Crowe, David T.; Redlich, Garry L.
Other Names:
Naik. Subhashchandra section editor.
Journal:
Medicine
Issue:
Volume 100:Issue 42(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Phase 1b dose-escalation, safety, and pharmacokinetic study of IC14, a monoclonal antibody against CD14, for the treatment of amyotrophic lateral sclerosis. Issue 42 (22nd October 2021)

Authors:
Henderson, Robert D.; Agosti, Jan M.; McCombe, Pamela A.; Thorpe, Kathryn; Heggie, Susan; Heshmat, Saman; Appleby, Mark W.; Ziegelaar, Brian W.; Crowe, David T.; Redlich, Garry L.
Editors:
Naik., Subhashchandra
Journal:
Medicine
Issue:
Volume 100:Issue 42(2021)
Page Start:
e27421
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search